TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Overview Fund Activity
Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

96 hedge funds and large institutions have $830M invested in Tetraphase Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+23
Holders Change %
+31.51%
% of All Funds
2.56%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.13%
New
35
Increased
37
Reduced
18
Closed
11
Calls
$3.67M
Puts
$4.99M
Net Calls
-$1.33M
Net Calls Change
-$1.19M

Top Buyers

1
BB
1
BB Biotech
Switzerland
$51.7M
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$41.1M
3
State Street
3
State Street
Massachusetts
$48.2M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$118M
5
IG
5
ING Group
Netherlands
$31.8M

Top Sellers

1
BC
1
Broadfin Capital
New York
$0
2
DM
2
Deerfield Management
New York
$0
3
Fidelity International
3
Fidelity International
Bermuda
$0
4
Nomura Holdings
4
Nomura Holdings
Japan
$0
5
TC
5
TFS Capital
Pennsylvania
$854K
Name Holding Trade Value Shares
Change 		Shares
Change %
GACM
101
Green Arrow Capital Management
New York
– -$1.2M -3,000 Closed
SIA
102
Sit Investment Associates
Minnesota
– -$705K -1,767 Closed
Goldman Sachs
103
Goldman Sachs
New York
– -$317K -793 Closed
LP
104
LMR Partners
United Kingdom
– -$235K -590 Closed
SFM
105
Sphera Funds Management
Israel
– -$47K -118 Closed
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
– -$26.4K -66 Closed
QT
107
Quantbot Technologies
New York
– -$9K -25 Closed
1 2 3 4
5